AI Engines For more Details: Perplexity Kagi Labs You
Bacterial Infections: Cefadroxil is effective against a wide range of bacterial infections, including those of the respiratory tract (e.g., bronchitis, pneumonia, tonsillitis), skin and soft tissues (e.g., cellulitis, wound infections), urinary tract (e.g., cystitis), and other infections caused by susceptible organisms.
Mechanism of Action: Cefadroxil works by inhibiting bacterial cell wall synthesis. It binds to penicillin-binding proteins (PBPs) located on the bacterial cell wall, disrupting the formation of peptidoglycan cross-links, ultimately leading to cell lysis and death.
Spectrum of Activity: Cefadroxil exhibits activity against both Gram-positive and Gram-negative bacteria. However, its spectrum of activity is broader against Gram-positive organisms, including Staphylococcus aureus and Streptococcus pyogenes, compared to some other cephalosporins.
Dosage Forms: Cefadroxil is available in various dosage forms, including capsules, tablets, and oral suspension. The choice of formulation depends on factors such as the age of the patient and the severity of the infection.
Adverse Effects: Common adverse effects of cefadroxil include gastrointestinal symptoms such as nausea, vomiting, diarrhea, and abdominal pain. Skin rash, itching, and allergic reactions may occur, particularly in individuals with a history of penicillin allergy. Anaphylactic reactions are rare but can be severe.
Renal Impairment: Dosage adjustment may be necessary in patients with renal impairment, as cefadroxil is primarily excreted by the kidneys. Accumulation of the drug can occur in patients with impaired renal function, leading to potential toxicity.
Pseudomembranous Colitis: Use of cefadroxil and other antibiotics can disrupt the normal balance of bacteria in the gastrointestinal tract and lead to the overgrowth of Clostridium difficile, resulting in pseudomembranous colitis, a potentially severe diarrheal illness.
Superinfections: Prolonged or repeated use of cefadroxil can lead to the development of superinfections caused by resistant organisms or fungi. Careful monitoring for the emergence of secondary infections is important during treatment.
Drug Interactions: Cefadroxil may interact with other medications, including probenecid, which can prolong the elimination half-life of the antibiotic by inhibiting renal tubular secretion. Caution should be exercised when co-administering cefadroxil with other drugs.
Administration: Cefadroxil is typically administered orally, with or without food, depending on the specific product and patient preferences. It is important to complete the full course of treatment as prescribed by the healthcare provider, even if symptoms improve before the medication is finished.
Rank | Probiotic | Impact |
---|---|---|
genus | Bifidobacterium | Reduces |
species | Akkermansia muciniphila | Reduces |
species | Anaerobutyricum hallii | Reduces |
species | Bifidobacterium adolescentis | Reduces |
species | Bifidobacterium bifidum | Reduces |
species | Bifidobacterium breve | Reduces |
species | Bifidobacterium catenulatum | Reduces |
species | Bifidobacterium longum | Reduces |
species | Christensenella minuta | Reduces |
species | Escherichia coli | Reduces |
species | Lactococcus cremoris | Reduces |
species | Streptococcus thermophilus | Reduces |
species | Veillonella atypica | Reduces |
subspecies | Bifidobacterium longum subsp. infantis | Reduces |
subspecies | Bifidobacterium longum subsp. longum | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
0 | 1 | Akkermansiaceae | family | Decreases |
0 | 1 | Blautia | genus | Decreases |
0 | 1 | Eggerthella | genus | Decreases |
0 | 1 | Veillonella | genus | Decreases |
0 | 1 | Bifidobacterium | genus | Decreases |
0 | 1 | Clostridium | genus | Decreases |
0 | 1 | Lachnospira | genus | Decreases |
0 | 1 | Odoribacter | genus | Decreases |
0 | 1 | Collinsella | genus | Decreases |
0 | 1 | Clostridioides | genus | Decreases |
0 | 1 | Roseburia | genus | Decreases |
0 | 1 | Escherichia | genus | Decreases |
0 | 1 | Dorea | genus | Decreases |
0 | 1 | Bacteroides | genus | Decreases |
0 | 1 | Streptococcus | genus | Decreases |
0 | 1 | Shigella | genus | Decreases |
0 | 1 | Coprococcus | genus | Decreases |
0 | 1 | Thomasclavelia | genus | Decreases |
0 | 1 | Lacrimispora | genus | Decreases |
0 | 1 | Parolsenella | genus | Decreases |
0 | 1 | Coprobacter | genus | Decreases |
0 | 1 | Allocoprobacillus | genus | Decreases |
0 | 1 | Ruminococcus | genus | Decreases |
0 | 1 | Mediterraneibacter | genus | Decreases |
1 | 0 | Akkermansia | genus | Decreases |
0 | 1 | Agathobacter | genus | Decreases |
0 | 1 | Clostridium perfringens A | no rank | Decreases |
0 | 1 | Clostridium perfringens B | no rank | Decreases |
0 | 1 | Clostridium perfringens C | no rank | Decreases |
0 | 1 | Clostridium perfringens CPE | no rank | Decreases |
0 | 1 | Clostridium perfringens D | no rank | Decreases |
0 | 1 | Clostridium perfringens E | no rank | Decreases |
0 | 1 | Escherichia coli O1:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O139:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O141:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O145:H34 | no rank | Decreases |
0 | 1 | Escherichia coli O15:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O155:H21 | no rank | Decreases |
0 | 1 | Escherichia coli O158:H23 | no rank | Decreases |
0 | 1 | Escherichia coli O16:H48 | no rank | Decreases |
0 | 1 | Escherichia coli O170:H18 | no rank | Decreases |
0 | 1 | Escherichia coli O18ac:H14 | no rank | Decreases |
0 | 1 | Escherichia coli O19:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H5 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O20:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O25:H16 | no rank | Decreases |
0 | 1 | Escherichia coli O55:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O68:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O7:H15 | no rank | Decreases |
0 | 1 | Escherichia coli O78:H51 | no rank | Decreases |
0 | 1 | Escherichia coli O80:H26 | no rank | Decreases |
0 | 1 | Escherichia coli O84:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O85:H1 | no rank | Decreases |
0 | 1 | environmental samples | no rank | Decreases |
0 | 1 | unclassified Akkermansia | no rank | Decreases |
0 | 1 | Escherichia coli O103 | serogroup | Decreases |
0 | 1 | Escherichia coli O111 | serogroup | Decreases |
0 | 1 | Escherichia coli O119 | serogroup | Decreases |
0 | 1 | Escherichia coli O121 | serogroup | Decreases |
0 | 1 | Escherichia coli O145 | serogroup | Decreases |
0 | 1 | Escherichia coli O155 | serogroup | Decreases |
0 | 1 | Escherichia coli O157 | serogroup | Decreases |
0 | 1 | Escherichia coli O177 | serogroup | Decreases |
0 | 1 | Escherichia coli O26 | serogroup | Decreases |
0 | 1 | Escherichia coli O3 | serogroup | Decreases |
0 | 1 | Escherichia coli O43 | serogroup | Decreases |
0 | 1 | Escherichia coli O5 | serogroup | Decreases |
0 | 1 | Escherichia coli O78 | serogroup | Decreases |
0 | 1 | Escherichia coli O86 | serogroup | Decreases |
0 | 1 | Escherichia coli O91 | serogroup | Decreases |
0 | 1 | Escherichia coli H20 | serotype | Decreases |
0 | 1 | Escherichia coli O1:H42 | serotype | Decreases |
0 | 1 | Escherichia coli O1:HNT | serotype | Decreases |
0 | 1 | Escherichia coli O10:H32 | serotype | Decreases |
0 | 1 | Escherichia coli O10:K5(L):H4 | serotype | Decreases |
0 | 1 | Escherichia coli O100:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H- | serotype | Decreases |
0 | 1 | Escherichia coli O111:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O111:NM | serotype | Decreases |
0 | 1 | Escherichia coli O112ab:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O112ac:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O113:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O114:H49 | serotype | Decreases |
0 | 1 | Escherichia coli O118:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O123:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O125ac:K+:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O126:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H27 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O128:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O128ac:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O139:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:NM | serotype | Decreases |
0 | 1 | Escherichia coli O146:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O15:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O150:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O152:H23 | serotype | Decreases |
0 | 1 | Escherichia coli O153:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O156:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H- | serotype | Decreases |
0 | 1 | Escherichia coli O157:H43 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O157:NM | serotype | Decreases |
0 | 1 | Escherichia coli O16:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O165:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O167:H26 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O176:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O177:NM | serotype | Decreases |
0 | 1 | Escherichia coli O2:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O2:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:NM | serotype | Decreases |
0 | 1 | Escherichia coli O26:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O26:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O28ac:NM | serotype | Decreases |
0 | 1 | Escherichia coli O29:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O32:H37 | serotype | Decreases |
0 | 1 | Escherichia coli O39:NM | serotype | Decreases |
0 | 1 | Escherichia coli O44:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O45:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16:CFA/II | serotype | Decreases |
0 | 1 | Escherichia coli O6:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O69:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O7:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O7:K1 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O79:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O8:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O81:NM | serotype | Decreases |
0 | 1 | Escherichia coli O83:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O86:H34 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H9 | serotype | Decreases |
0 | 1 | Escherichia coli O9:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O91:H14 | serotype | Decreases |
0 | 1 | Escherichia coli O91:NM | serotype | Decreases |
0 | 1 | Escherichia coli O99:H6 | serotype | Decreases |
0 | 1 | Escherichia coli ONT:H33 | serotype | Decreases |
1 | 0 | Clostridioides difficile | species | Decreases |
1 | 0 | Streptococcus salivarius | species | Decreases |
1 | 0 | Bacteroides xylanisolvens | species | Decreases |
1 | 0 | Bifidobacterium adolescentis | species | Decreases |
1 | 0 | Bifidobacterium longum | species | Decreases |
1 | 0 | Blautia obeum | species | Decreases |
1 | 0 | Clostridium perfringens | species | Decreases |
1 | 0 | Collinsella aerofaciens | species | Decreases |
1 | 0 | Eggerthella lenta | species | Decreases |
1 | 0 | Lachnospira eligens | species | Decreases |
1 | 0 | Odoribacter splanchnicus | species | Decreases |
1 | 0 | Roseburia hominis | species | Decreases |
1 | 0 | Veillonella parvula | species | Decreases |
1 | 0 | Bacteroides ovatus | species | Decreases |
1 | 0 | Escherichia coli | species | Decreases |
1 | 0 | Dorea formicigenerans | species | Decreases |
1 | 0 | Bacteroides caccae | species | Decreases |
0 | 1 | Streptococcus sp. FDAARGOS_192 | species | Decreases |
1 | 0 | Coprococcus comes | species | Decreases |
0 | 1 | Veillonella rodentium | species | Decreases |
1 | 0 | Thomasclavelia ramosa | species | Decreases |
1 | 0 | Lacrimispora saccharolytica | species | Decreases |
0 | 1 | Shigella dysenteriae | species | Decreases |
0 | 1 | Shigella flexneri | species | Decreases |
0 | 1 | Escherichia albertii | species | Decreases |
0 | 1 | Veillonella dispar | species | Decreases |
0 | 1 | Eggerthella guodeyinii | species | Decreases |
0 | 1 | Escherichia fergusonii | species | Decreases |
1 | 0 | Streptococcus parasanguinis | species | Decreases |
0 | 1 | Bifidobacterium breve | species | Decreases |
0 | 1 | Veillonella sp. S12025-13 | species | Decreases |
0 | 1 | Bacteroides luhongzhouii | species | Decreases |
0 | 1 | Bifidobacterium angulatum | species | Decreases |
0 | 1 | Veillonella nakazawae | species | Decreases |
1 | 0 | Ruminococcus bromii | species | Decreases |
0 | 1 | Shigella boydii | species | Decreases |
0 | 1 | Streptococcus sp. LPB0220 | species | Decreases |
0 | 1 | Streptococcus sp. HSISM1 | species | Decreases |
0 | 1 | Parolsenella catena | species | Decreases |
1 | 0 | Roseburia intestinalis | species | Decreases |
0 | 1 | Veillonella rogosae | species | Decreases |
0 | 1 | Parolsenella massiliensis | species | Decreases |
0 | 1 | Bacteroides sp. D2 | species | Decreases |
0 | 1 | Coprococcus catus | species | Decreases |
0 | 1 | Collinsella stercoris | species | Decreases |
0 | 1 | Dorea longicatena | species | Decreases |
0 | 1 | Wansuia hejianensis | species | Decreases |
0 | 1 | Bacteroides sp. DH3716P | species | Decreases |
0 | 1 | Anaerobutyricum hallii | species | Decreases |
0 | 1 | Bacteroides sp. M10 | species | Decreases |
0 | 1 | Coprobacter secundus | species | Decreases |
0 | 1 | Butyricimonas faecalis | species | Decreases |
0 | 1 | Butyrivibrio crossotus | species | Decreases |
0 | 1 | Streptococcus vestibularis | species | Decreases |
0 | 1 | Veillonella atypica | species | Decreases |
0 | 1 | Blautia sp. SC05B48 | species | Decreases |
0 | 1 | Ligilactobacillus ruminis | species | Decreases |
0 | 1 | Barnesiella viscericola | species | Decreases |
0 | 1 | Eubacterium ventriosum | species | Decreases |
0 | 1 | Alistipes megaguti | species | Decreases |
0 | 1 | Butyricimonas virosa | species | Decreases |
0 | 1 | Eubacterium sp. MSJ-33 | species | Decreases |
0 | 1 | Komagataeibacter oboediens | species | Decreases |
0 | 1 | Clostridium sp. M62/1 | species | Decreases |
0 | 1 | Shigella sonnei | species | Decreases |
0 | 1 | Subdoligranulum variabile | species | Decreases |
0 | 1 | Bifidobacterium catenulatum | species | Decreases |
0 | 1 | Clostridium sp. SY8519 | species | Decreases |
0 | 1 | Coprobacter fastidiosus | species | Decreases |
0 | 1 | Escherichia marmotae | species | Decreases |
0 | 1 | Roseburia rectibacter | species | Decreases |
0 | 1 | Bacteroides faecium | species | Decreases |
0 | 1 | Coprococcus eutactus | species | Decreases |
0 | 1 | Hungatella hathewayi | species | Decreases |
0 | 1 | Wujia chipingensis | species | Decreases |
0 | 1 | Faecalibacterium duncaniae | species | Decreases |
0 | 1 | Alistipes sp. dk3624 | species | Decreases |
0 | 1 | Escherichia sp. E4742 | species | Decreases |
0 | 1 | [Ruminococcus] lactaris | species | Decreases |
0 | 1 | Blautia liquoris | species | Decreases |
0 | 1 | Qiania dongpingensis | species | Decreases |
0 | 1 | Massilistercora timonensis | species | Decreases |
0 | 1 | Pseudobutyrivibrio xylanivorans | species | Decreases |
0 | 1 | Fannyhessea vaginae | species | Decreases |
0 | 1 | Alistipes finegoldii | species | Decreases |
0 | 1 | Faecalibacillus intestinalis | species | Decreases |
0 | 1 | Vescimonas fastidiosa | species | Decreases |
0 | 1 | Novisyntrophococcus fermenticellae | species | Decreases |
0 | 1 | Actinomyces naeslundii | species | Decreases |
0 | 1 | Alistipes onderdonkii | species | Decreases |
0 | 1 | Intestinibaculum porci | species | Decreases |
0 | 1 | Amedibacterium intestinale | species | Decreases |
0 | 1 | Bifidobacterium bifidum | species | Decreases |
0 | 1 | Adlercreutzia equolifaciens | species | Decreases |
0 | 1 | Faecalitalea cylindroides | species | Decreases |
0 | 1 | Parafannyhessea umbonata | species | Decreases |
0 | 1 | Alistipes senegalensis | species | Decreases |
0 | 1 | Catenibacterium mitsuokai | species | Decreases |
0 | 1 | [Clostridium] hylemonae | species | Decreases |
0 | 1 | Alistipes communis | species | Decreases |
0 | 1 | Vescimonas coprocola | species | Decreases |
0 | 1 | Coprococcus sp. ART55/1 | species | Decreases |
0 | 1 | Simiaoa sunii | species | Decreases |
0 | 1 | Eubacterium limosum | species | Decreases |
0 | 1 | Christensenella minuta | species | Decreases |
0 | 1 | Mageeibacillus indolicus | species | Decreases |
1 | 0 | [Ruminococcus] torques | species | Decreases |
0 | 1 | Bacteroides caecimuris | species | Decreases |
0 | 1 | Ruminococcus gauvreauii | species | Decreases |
0 | 1 | Alistipes shahii | species | Decreases |
0 | 1 | Ruminococcus bicirculans (ex Wegman et al. 2014) | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-1-79 | species | Decreases |
0 | 1 | uncultured Alistipes sp. | species | Decreases |
0 | 1 | Streptococcus lactarius | species | Decreases |
0 | 1 | Faecalibacterium sp. I2-3-92 | species | Decreases |
0 | 1 | Gordonibacter urolithinfaciens | species | Decreases |
0 | 1 | Olsenella sp. oral taxon 807 | species | Decreases |
0 | 1 | Eubacterium callanderi | species | Decreases |
0 | 1 | Anaerostipes hadrus | species | Decreases |
0 | 1 | Streptococcus gordonii | species | Decreases |
0 | 1 | Ruthenibacterium lactatiformans | species | Decreases |
0 | 1 | Monoglobus pectinilyticus | species | Decreases |
0 | 1 | Marvinbryantia formatexigens | species | Decreases |
0 | 1 | Streptococcus thermophilus | species | Decreases |
0 | 1 | Streptococcus sp. oral taxon 061 | species | Decreases |
0 | 1 | Streptococcus suis | species | Decreases |
0 | 1 | Ruminococcus champanellensis | species | Decreases |
0 | 1 | Eubacterium sp. c-25 | species | Decreases |
0 | 1 | Ruminococcus albus | species | Decreases |
0 | 1 | Parabacteroides merdae | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-3-84 | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-3-29 | species | Decreases |
0 | 1 | Lachnoclostridium phocaeense | species | Decreases |
0 | 1 | Faecalibacterium sp. HTF-F | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-1-18 | species | Decreases |
0 | 1 | Maliibacterium massiliense | species | Decreases |
0 | 1 | Eubacterium maltosivorans | species | Decreases |
0 | 1 | Parvimonas micra | species | Decreases |
0 | 1 | Alistipes ihumii | species | Decreases |
0 | 1 | Faecalibacterium sp. I3-3-33 | species | Decreases |
0 | 1 | Catenibacterium sp. co_0103 | species | Decreases |
0 | 1 | Longicatena caecimuris | species | Decreases |
0 | 1 | Lachnoanaerobaculum gingivalis | species | Decreases |
0 | 1 | Clostridium cadaveris | species | Decreases |
0 | 1 | Bacteroides nordii | species | Decreases |
0 | 1 | Oscillibacter hominis | species | Decreases |
0 | 1 | Mogibacterium diversum | species | Decreases |
0 | 1 | Bacteroides intestinalis | species | Decreases |
0 | 1 | Streptococcus australis | species | Decreases |
0 | 1 | Actinomyces sp. oral taxon 169 | species | Decreases |
0 | 1 | Leyella stercorea | species | Decreases |
0 | 1 | Treponema peruense | species | Decreases |
0 | 1 | Actinomyces oris | species | Decreases |
0 | 1 | Arabiibacter massiliensis | species | Decreases |
0 | 1 | Lactococcus cremoris | species | Decreases |
0 | 1 | Faecalibacterium sp. I3-3-89 | species | Decreases |
0 | 1 | [Eubacterium] hominis | species | Decreases |
1 | 0 | Mediterraneibacter gnavus | species | Decreases |
1 | 0 | Akkermansia muciniphila | species | Decreases |
1 | 0 | Bacteroides thetaiotaomicron | species | Decreases |
1 | 0 | Agathobacter rectalis | species | Decreases |
0 | 1 | Akkermansia glycaniphila | species | Decreases |
0 | 1 | Akkermansia massiliensis | species | Decreases |
0 | 1 | Candidatus Akkermansia intestinavium | species | Decreases |
0 | 1 | Bifidobacterium longum subsp. infantis | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. longum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suillum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suis | subspecies | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0 | 0 | |
Acne | 0.4 | -0.4 | |
ADHD | 3.2 | 0.9 | 2.56 |
Age-Related Macular Degeneration and Glaucoma | 0.7 | 0.7 | |
Allergic Rhinitis (Hay Fever) | 2.5 | 2.9 | -0.16 |
Allergies | 6.8 | 2.1 | 2.24 |
Allergy to milk products | 1.9 | 1.1 | 0.73 |
Alopecia (Hair Loss) | 1.1 | 0.1 | 10 |
Alzheimer's disease | 4.2 | 5.5 | -0.31 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 2.4 | 0.7 | 2.43 |
Ankylosing spondylitis | 4 | 0.8 | 4 |
Anorexia Nervosa | 1.7 | 2.6 | -0.53 |
Antiphospholipid syndrome (APS) | 1 | 1 | |
Asthma | 6 | 2.4 | 1.5 |
Atherosclerosis | 1.8 | 1.5 | 0.2 |
Atrial fibrillation | 2.8 | 1.1 | 1.55 |
Autism | 7.2 | 7 | 0.03 |
Autoimmune Disease | 1.1 | 1.2 | -0.09 |
Barrett esophagus cancer | 0.5 | 0.2 | 1.5 |
benign prostatic hyperplasia | 0.4 | 0.2 | 1 |
Biofilm | 1.7 | 1.7 | |
Bipolar Disorder | 1.7 | 1.5 | 0.13 |
Brain Trauma | 1.1 | 1.1 | 0 |
Breast Cancer | 0.5 | 0.5 | |
Cancer (General) | 0.9 | 2.5 | -1.78 |
Carcinoma | 3.3 | 2.3 | 0.43 |
Celiac Disease | 2.6 | 3.5 | -0.35 |
Cerebral Palsy | 1.8 | 1.1 | 0.64 |
Chronic Fatigue Syndrome | 5 | 4.6 | 0.09 |
Chronic Kidney Disease | 3.7 | 1.7 | 1.18 |
Chronic Lyme | 0.7 | 0.5 | 0.4 |
Chronic Obstructive Pulmonary Disease (COPD) | 2.4 | 1.6 | 0.5 |
Chronic Urticaria (Hives) | 1.9 | 0.1 | 18 |
Coagulation / Micro clot triggering bacteria | 1.2 | 1.1 | 0.09 |
Cognitive Function | 1.6 | 1.8 | -0.13 |
Colorectal Cancer | 5.1 | 2.5 | 1.04 |
Constipation | 1.2 | 0.8 | 0.5 |
Coronary artery disease | 1.9 | 2.4 | -0.26 |
COVID-19 | 9.8 | 9.9 | -0.01 |
Crohn's Disease | 5.7 | 4.2 | 0.36 |
Cushing's Syndrome (hypercortisolism) | 0.2 | -0.2 | |
cystic fibrosis | 0.8 | 2.1 | -1.63 |
d-lactic acidosis (one form of brain fog) | 0.5 | 0.5 | |
deep vein thrombosis | 1.2 | 0.8 | 0.5 |
Denture Wearers Oral Shifts | 1.5 | 1.5 | |
Depression | 8.3 | 7.5 | 0.11 |
Dermatomyositis | 0.2 | 0.4 | -1 |
Eczema | 1.7 | 2.3 | -0.35 |
Endometriosis | 2.8 | 2.4 | 0.17 |
Eosinophilic Esophagitis | 0.7 | -0.7 | |
Epilepsy | 3.6 | 1.4 | 1.57 |
erectile dysfunction | 1.1 | 0.4 | 1.75 |
Fibromyalgia | 3.1 | 1.4 | 1.21 |
Functional constipation / chronic idiopathic constipation | 4.7 | 2.8 | 0.68 |
gallstone disease (gsd) | 2.7 | 0.8 | 2.38 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.5 | 1.7 | -2.4 |
Generalized anxiety disorder | 2.7 | 2.1 | 0.29 |
giant cell arteritis | 0.4 | -0.4 | |
Glioblastoma | 0.2 | -0.2 | |
Gout | 1.5 | 0.8 | 0.88 |
Graves' disease | 1.6 | 3 | -0.88 |
Gulf War Syndrome | 1.3 | 0.6 | 1.17 |
Halitosis | 0.9 | 0.2 | 3.5 |
Hashimoto's thyroiditis | 2.6 | 1.2 | 1.17 |
Heart Failure | 3.5 | 1.6 | 1.19 |
hemorrhagic stroke | 0.2 | 0.2 | |
Hidradenitis Suppurativa | 0.9 | 0.5 | 0.8 |
High Histamine/low DAO | 1.9 | 0.5 | 2.8 |
hypercholesterolemia (High Cholesterol) | 1.4 | 0.1 | 13 |
hyperglycemia | 2.4 | 1.3 | 0.85 |
Hyperlipidemia (High Blood Fats) | 0.9 | 0.4 | 1.25 |
hypersomnia | 0.9 | -0.9 | |
hypertension (High Blood Pressure | 3.3 | 5.1 | -0.55 |
Hypothyroidism | 0 | 1.6 | 0 |
Hypoxia | 2 | 2 | |
IgA nephropathy (IgAN) | 1 | 3.8 | -2.8 |
Inflammatory Bowel Disease | 8.7 | 7.8 | 0.12 |
Insomnia | 2.6 | 2.6 | 0 |
Intelligence | 1.7 | 1.7 | |
Intracranial aneurysms | 0.8 | 0.7 | 0.14 |
Irritable Bowel Syndrome | 5.7 | 3.9 | 0.46 |
ischemic stroke | 3.1 | 1 | 2.1 |
Liver Cirrhosis | 6.7 | 3.4 | 0.97 |
Long COVID | 5.6 | 6.8 | -0.21 |
Low bone mineral density | 1.1 | -1.1 | |
Lung Cancer | 0.8 | 1.2 | -0.5 |
Lymphoma | 0.4 | 0.1 | 3 |
Mast Cell Issues / mastitis | 0.7 | 0.7 | 0 |
ME/CFS with IBS | 0.6 | 2.5 | -3.17 |
ME/CFS without IBS | 2 | 1.6 | 0.25 |
membranous nephropathy | 0.2 | 0.2 | |
Menopause | 2.4 | 0.4 | 5 |
Metabolic Syndrome | 6.3 | 5.9 | 0.07 |
Mood Disorders | 8.9 | 6.6 | 0.35 |
multiple chemical sensitivity [MCS] | 1.5 | 0.5 | 2 |
Multiple Sclerosis | 6.7 | 4.3 | 0.56 |
Multiple system atrophy (MSA) | 1 | 1 | 0 |
myasthenia gravis | 0.7 | 0.7 | 0 |
neuropathic pain | 0.5 | 2.5 | -4 |
Neuropathy (all types) | 1.2 | 1.2 | 0 |
neuropsychiatric disorders (PANDAS, PANS) | 1.2 | 1.2 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 5.2 | 4.7 | 0.11 |
NonCeliac Gluten Sensitivity | 2.1 | 0.7 | 2 |
Obesity | 8.6 | 6.5 | 0.32 |
obsessive-compulsive disorder | 4.5 | 2.5 | 0.8 |
Osteoarthritis | 2.4 | 1.1 | 1.18 |
Osteoporosis | 2.5 | 1.5 | 0.67 |
pancreatic cancer | 0.6 | 0.2 | 2 |
Parkinson's Disease | 7.8 | 5.1 | 0.53 |
Polycystic ovary syndrome | 3.8 | 2.9 | 0.31 |
Postural orthostatic tachycardia syndrome | 0.4 | 0.7 | -0.75 |
Premenstrual dysphoric disorder | 1.3 | 1.3 | |
primary biliary cholangitis | 0.9 | 1 | -0.11 |
Primary sclerosing cholangitis | 2.4 | 2.1 | 0.14 |
Psoriasis | 3.8 | 0.8 | 3.75 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 6 | 3.6 | 0.67 |
Rosacea | 0.7 | 0.7 | 0 |
Schizophrenia | 7 | 3.1 | 1.26 |
scoliosis | 0.8 | 0.7 | 0.14 |
sensorineural hearing loss | 0.3 | 0.3 | |
Sjögren syndrome | 2.8 | 2 | 0.4 |
Sleep Apnea | 1.6 | 1.7 | -0.06 |
Slow gastric motility / Gastroparesis | 1.4 | 0.4 | 2.5 |
Small Intestinal Bacterial Overgrowth (SIBO) | 2.1 | 0.6 | 2.5 |
Stress / posttraumatic stress disorder | 2.4 | 2.2 | 0.09 |
Systemic Lupus Erythematosus | 3.4 | 2.6 | 0.31 |
Tic Disorder | 0.7 | 1.4 | -1 |
Tourette syndrome | 0.5 | 0.2 | 1.5 |
Type 1 Diabetes | 3.2 | 3.8 | -0.19 |
Type 2 Diabetes | 6 | 4.7 | 0.28 |
Ulcerative colitis | 5 | 4.5 | 0.11 |
Unhealthy Ageing | 2.8 | 1.5 | 0.87 |
Vitiligo | 1.4 | 1.4 | 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]